Elisabetta Bugianesi
Impact in
- Hepatology top 0.02%
- Liver Disease and Transplantation
- Hepatitis C virus research
- Liver Diseases and Immunity
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
Papers in
- Hepatology 121
- Liver Disease and Transplantation 63
- Liver Diseases and Immunity 33
- Hepatitis C virus research 33
- Epidemiology 273
- Liver Disease Diagnosis and Treatment 261
- Co-authors
- Giulio MarchesiniEster VanniZobair M. YounossiArthur J. McCulloughJacob GeorgeQuentin M. AnsteeGabriele ForlaniNazario Melchionda
- Journals
- Journal of Hepatology (37 papers)Hepatology (28 papers)Digestive and Liver Disease (24 papers)Liver International (12 papers)Journal of Clinical Medicine (11 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
Elisabetta Bugianesi
282 papers receiving 32.6k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Hepatology 10.6k
- Epidemiology 27.9k
- Endocrinology, Diabetes and Metabolism 12.9k
- Pathology and Forensic Medicine 4.2k
- Physiology 4.8k
Countries citing papers authored by Elisabetta Bugianesi
This map shows the geographic impact of Elisabetta Bugianesi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabetta Bugianesi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabetta Bugianesi more than expected).
Fields of papers citing papers by Elisabetta Bugianesi
This network shows the impact of papers produced by Elisabetta Bugianesi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabetta Bugianesi. The network helps show where Elisabetta Bugianesi may publish in the future.
Co-authors
The 25 scholars most cited alongside Elisabetta Bugianesi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 27 | |
| 5 | 2023 | 9 | |
| 6 | Global epidemiology of cirrhosis — aetiology, trends and predictions Hit paper breakdown → | 2023 | 381 |
| 7 | 2023 | 4 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 47 | |
| 10 | 2022 | 18 | |
| 11 | 2022 | 64 | |
| 12 | 2021 | 11 | |
| 13 | 2020 | 1 | |
| 14 | The PanPPAR agonist lanifibranor induces both resolution of NASH and regression of fibrosis after 24 weeks of treatment in non-cirrhotic NASH: results of the NATIVE Phase 2b trial | 2020 | 18 |
| 15 | 2020 | 13 | |
| 16 | 2020 | 23 | |
| 17 | 2019 | 82 | |
| 18 | 2019 | 82 | |
| 19 | 2019 | 26 | |
| 20 | 2019 | 60 |
About Elisabetta Bugianesi
Elisabetta Bugianesi is a scholar working on Hepatology, Epidemiology, Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Physiology, having authored 298 papers that have together received 33.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (261 papers), Diet, Metabolism, and Disease (95 papers), Liver Disease and Transplantation (63 papers), Liver Diseases and Immunity (33 papers), Hepatitis C virus research (33 papers), Alcohol Consumption and Health Effects (31 papers), Pancreatitis Pathology and Treatment (30 papers) and Diet and metabolism studies (25 papers). The work is most often cited by research in Hepatology (10.6k citations), Epidemiology (27.9k citations), Endocrinology, Diabetes and Metabolism (12.9k citations), Pathology and Forensic Medicine (4.2k citations) and Physiology (4.8k citations). Elisabetta Bugianesi has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include Giulio Marchesini, Ester Vanni, Zobair M. Younossi, Arthur J. McCullough, Jacob George, Quentin M. Anstee, Gabriele Forlani, Nazario Melchionda, M. Marietti and Mohammed Eslam. Their work appears in journals such as Journal of Hepatology, Hepatology, Digestive and Liver Disease, Liver International and Journal of Clinical Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.